Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Moderna’s COVID-19 vaccine has produced a strong immune response in early trials – but will it be able to prevent infections on a large scale? 

Doubts over US government plans for COVID-19 vaccine

There are doubts about the US government's plans to have 300 million COVID-19 vaccine doses ready by the end of the year, after the front-running candidate from Moderna advanced to mid-stag

Sixth COVID-19 vaccine clinical trial begins at UK's Oxford ...

The UK government is throwing £42.5 million at two potential coronavirus vaccine candidates as it steps up efforts to fight the pandemic, as Oxford University scientists began the sixth cli

US government gives Moderna $483m for COVID-19 vaccine

Inovio begins clinical trial of COVID-19 vaccine

US-based Inovio has become the third biotech to begin clinical development of a vaccine against the COVID-19 coronavirus.

GSK to collaborate with Chinese biotech on COVID-19 vaccine

GlaxoSmithKline has announced plans to collaborate with China’s Xiamen Innovex on a potential vaccine to treat the COVID-19 coronavirus.